Relative Bioavailability of Ibuprofen Sustained-release Capsules in Human Subjects

刘建芳,邓鸣,赵春丽,刘会臣

DOI: https://doi.org/10.3969/j.issn.1001-6821.2003.02.008

2003-01-01

Abstract:OBJECTIVE: To compare the bioavailability of domestic ibuprofen sustained-release capsules and fenbid capsules in human subjects. METHODS: A single and multiple oral administration of 600mg test and reference capsules were given to 20 healthy male volunteers according to randomized crossover design. Ibuprofen concentrations in serum were determined by HPLC methods. The pharmacokinetics parameters and bioavailability of test capsules were compared with those of reference capsules. RESULTS: After a single oral administration of 600mg test and reference capsules, the pharmacokinetic parameters were as follows: AUC0-24 were 208.74 ± 43.74 and 205.54 ± 39.43 mg·L-1·h, tmax were 4.85 ± 0.81 and 5.20 ± 1.06 h , Cmax were 25.40 ± 4.00 and 25.47 ± 4.50 mg·L-1, respectively. The relative bioavailability of test capsules was (104.13 ± 25.50)%. After multiple oral administration of 600mg test and reference capsules , the pharmacokinetics parameters were as follows: AUCss were 170.81 ± 24.87 and 172.93 ± 29.76 mg·h·L-1, tmax were 4.90 ± 0.97 and 4.65 ± 1.09 h, Cmax were 27.31±5.45 and 26.87 ± 3.79 mg·L-1, Cmin were 6.13 ± 1.60 and 5.94 ± 1.84 mg·L-1, DF were ( 146.45 ± 36.69) %and(149.10±22.61)%,respectively.The relative bioavailability of test capsules was (99.68 ± 10.22)%. CONCLUSION: The two preparations were bioequivalent.